These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 7256544)

  • 21. Chemotaxis of horse polymorphonuclear leukocytes to N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Zinkl JG; Brown PD
    Am J Vet Res; 1982 Apr; 43(4):613-6. PubMed ID: 7073083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human C5a modulates monocyte Fc and C3 receptor expression.
    Yancey KB; O'Shea J; Chused T; Brown E; Takahashi T; Frank MM; Lawley TJ
    J Immunol; 1985 Jul; 135(1):465-70. PubMed ID: 3158706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro.
    Tonnesen MG; Smedly LA; Henson PM
    J Clin Invest; 1984 Nov; 74(5):1581-92. PubMed ID: 6501563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
    Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
    Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of filter-bound IgA in inhibiting polymorphonuclear leukocyte chemotaxis.
    Schröder JM; Christophers E
    Immunobiology; 1983 Mar; 164(2):127-35. PubMed ID: 6852861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotactic deactivation of human neutrophils: relationship to loss of cytotaxin receptor function and temporal nature of the phenomenon.
    Nelson RD; Fiegel VD; Herron MJ; Simmons RL
    J Reticuloendothel Soc; 1980 Sep; 28(3):285-94. PubMed ID: 7411541
    [No Abstract]   [Full Text] [Related]  

  • 29. Specificity and reversibility of chemotactic deactivation of human monocytes.
    Falk W; Leonard EJ
    Infect Immun; 1981 May; 32(2):464-8. PubMed ID: 6265358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonsteroidal anti-inflammatory drug as tools for analysis of neutrophil functions.
    Périanin A; Giroud JP; Hakim J
    Biomed Pharmacother; 1987; 41(6):315-21. PubMed ID: 3446289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulus-specific deactivation of chemotactic factor-induced cyclic AMP response and superoxide generation by human neutrophils.
    Simchowitz L; Atkinson JP; Spilberg I
    J Clin Invest; 1980 Oct; 66(4):736-47. PubMed ID: 6252250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphonuclear leucocyte locomotion and aggregation in patients with alcoholic liver disease.
    Rajkovic IA; Yousif-Kadaru AG; Wyke RJ; Williams R
    Clin Exp Immunol; 1984 Dec; 58(3):654-62. PubMed ID: 6509797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil activation in thermal injury as assessed by increased expression of complement receptors.
    Moore FD; Davis C; Rodrick M; Mannick JA; Fearon DT
    N Engl J Med; 1986 Apr; 314(15):948-53. PubMed ID: 2938005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered free cytosolic calcium changes and neutrophil chemotaxis in patients with juvenile periodontitis.
    Agarwal S; Reynolds MA; Duckett LD; Suzuki JB
    J Periodontal Res; 1989 Mar; 24(2):149-54. PubMed ID: 2524580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
    Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
    J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
    Belenky SN; Robbins RA; Rennard SI; Gossman GL; Nelson KJ; Rubinstein I
    J Lab Clin Med; 1993 Oct; 122(4):388-94. PubMed ID: 7693839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of monocyte chemotactic function in inflammatory lesions. Role of inflammatory mediators.
    Katona IM; Ohura K; Allen JB; Wahl LM; Chenoweth DE; Wahl SM
    J Immunol; 1991 Jan; 146(2):708-14. PubMed ID: 1898961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for 5, 12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation.
    O'Flaherty JT; Hammett MJ; Shewmake TB; Wykle RL; Love SH; McCall CE; Thomas MJ
    Biochem Biophys Res Commun; 1981 Nov; 103(2):552-8. PubMed ID: 6277309
    [No Abstract]   [Full Text] [Related]  

  • 39. Neutrophil chemotaxis in rhesus macaques (Macaca mulatta).
    Gonder JC; Thomas JM; Payne ES
    Am J Vet Res; 1986 Apr; 47(4):860-2. PubMed ID: 3963588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in chemotactic factor-induced responses of neutrophils and monocytes from chronic dialysis patients.
    Lewis SL; Van Epps DE; Chenoweth DE
    Clin Nephrol; 1988 Aug; 30(2):63-72. PubMed ID: 2846218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.